Ultralife Corporation to Report Fourth Quarter Results on March 11, 2025
Ultralife (NASDAQ: ULBI) has scheduled its fourth quarter 2024 financial results release for March 11, 2025, before market opening. The delayed reporting timeline, later than the company's usual practice of reporting in the sixth week after year-end, is attributed to additional time needed to complete the accounting close and audit of Electrochem Solutions, Inc., which was acquired on October 31, 2024.
Management will host an investor conference call and webcast at 8:30 AM ET on the same day. Participants joining by phone must pre-register through a provided link to ensure reliable connection. A live webcast will be available on the company's website, with a replay accessible shortly after the call.
Ultralife (NASDAQ: ULBI) ha programmato il rilascio dei risultati finanziari del quarto trimestre 2024 per l'11 marzo 2025, prima dell'apertura del mercato. Il ritardo nella comunicazione dei risultati, rispetto alla consueta pratica dell'azienda di riportare i risultati nella sesta settimana dopo la fine dell'anno, è attribuito al tempo aggiuntivo necessario per completare la chiusura contabile e la revisione di Electrochem Solutions, Inc., acquisita il 31 ottobre 2024.
La direzione terrà una conferenza telefonica per gli investitori e una diretta streaming alle 8:30 AM ET dello stesso giorno. I partecipanti che si uniscono per telefono devono registrarsi in anticipo attraverso un link fornito per garantire una connessione affidabile. Una diretta streaming sarà disponibile sul sito web dell'azienda, con una registrazione accessibile poco dopo la chiamata.
Ultralife (NASDAQ: ULBI) ha programado la publicación de sus resultados financieros del cuarto trimestre de 2024 para el 11 de marzo de 2025, antes de la apertura del mercado. El retraso en el cronograma de informes, más tarde de lo habitual para la empresa, que suele informar en la sexta semana después del cierre del año, se debe al tiempo adicional necesario para completar el cierre contable y la auditoría de Electrochem Solutions, Inc., adquirida el 31 de octubre de 2024.
La dirección llevará a cabo una conferencia telefónica para inversores y una transmisión en vivo a las 8:30 AM ET el mismo día. Los participantes que se unan por teléfono deben registrarse previamente a través de un enlace proporcionado para garantizar una conexión confiable. Una transmisión en vivo estará disponible en el sitio web de la empresa, con una repetición accesible poco después de la llamada.
Ultralife (NASDAQ: ULBI)는 2025년 3월 11일에 2024년 4분기 재무 결과 발표를 예정하고 있으며, 시장 개장 전에 이루어질 것입니다. 보고 일정의 지연은 연말 후 6주 이내에 보고하는 회사의 일반적인 관행보다 늦어지며, Electrochem Solutions, Inc.의 회계 마감 및 감사 완료를 위해 추가적인 시간이 필요했기 때문입니다. 이 회사는 2024년 10월 31일에 인수되었습니다.
경영진은 같은 날 오전 8시 30분 ET에 투자자 콘퍼런스 콜 및 웹캐스트를 개최할 예정입니다. 전화로 참여하는 참가자는 제공된 링크를 통해 미리 등록해야 안정적인 연결을 보장할 수 있습니다. 회사 웹사이트에서는 생중계가 제공되며, 콜 직후에 재생할 수 있는 녹화본도 이용할 수 있습니다.
Ultralife (NASDAQ: ULBI) a prévu la publication de ses résultats financiers du quatrième trimestre 2024 pour le 11 mars 2025, avant l'ouverture du marché. Le calendrier de reporting retardé, qui est plus tard que la pratique habituelle de l'entreprise de publier dans la sixième semaine après la fin de l'année, est attribué au temps supplémentaire nécessaire pour finaliser la clôture comptable et l'audit de Electrochem Solutions, Inc., acquise le 31 octobre 2024.
La direction organisera une conférence téléphonique pour les investisseurs et un webinaire le même jour à 8h30 ET. Les participants rejoignant par téléphone doivent s'inscrire à l'avance via un lien fourni pour garantir une connexion fiable. Un webinaire en direct sera disponible sur le site web de l'entreprise, avec une rediffusion accessible peu après l'appel.
Ultralife (NASDAQ: ULBI) hat die Veröffentlichung der finanziellen Ergebnisse für das vierte Quartal 2024 auf den 11. März 2025 vor der Markteröffnung angesetzt. Der verzögerte Berichtstermin, der später als die übliche Praxis des Unternehmens liegt, die Ergebnisse in der sechsten Woche nach Jahresende zu veröffentlichen, wird auf die zusätzliche Zeit zurückgeführt, die benötigt wird, um den Abschluss der Buchhaltung und die Prüfung von Electrochem Solutions, Inc., die am 31. Oktober 2024 übernommen wurde, abzuschließen.
Das Management wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz für Investoren und ein Webcast abhalten. Teilnehmer, die telefonisch teilnehmen möchten, müssen sich über einen bereitgestellten Link im Voraus registrieren, um eine zuverlässige Verbindung sicherzustellen. Ein Live-Webcast wird auf der Website des Unternehmens verfügbar sein, mit einer Aufzeichnung, die kurz nach dem Anruf zugänglich ist.
- Strategic acquisition of Electrochem Solutions completed in Q4 2024
- Delayed earnings report from usual timeline
NEWARK, N.Y., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2024 before the market opens on Tuesday, March 11, 2025. Due to the time required to complete the accounting close and audit of the financial results of Electrochem Solutions, Inc., which the Company acquired on October 31, 2024, Ultralife is reporting fourth quarter results later than it has in the past, in contrast to its established practice of reporting fourth quarter results on the Thursday of the sixth week after year end.
Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 11, 2025. Please see the call-in procedures which follow below.
NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE:
To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI1a1f31c093654241b376ab0dfc2c088b. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again.
A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
| Company Contact: | Investor Relations Contact: |
| Ultralife Corporation | Alliance Advisors IR |
| Philip A. Fain | Jody Burfening/Alex Villalta |
| (315) 210-6110 | (212) 838-3777 |
| pfain@ulbi.com | avillalta@allianceadvisors.com |
FAQ
When will Ultralife (ULBI) release Q4 2024 earnings?
Why is ULBI's Q4 2024 earnings report delayed?
What is the recent acquisition made by Ultralife (ULBI)?
How can investors participate in ULBI's Q4 2024 earnings call?
